Edesa Biotech EDSA Cash Flow Statement (2013-2026)

NASDAQ EDSA
$4.28 -0.48 (-9.80%)
As of: Aug 21, 2026 · 2:55 PM EDT
Cash Flow Statement Aug2013 Dec2013 Aug2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-4.76M-0.15M-5.26M-4.57M-5.79M1.84M-4.10M-2.33M-1.98M-2.06M-3.47M-1.86M-1.67M-1.11M-2.00M-1.59M-1.75M-2.43M-2.44M-5.41M
Depreciation and Depletion (Quarter)
2,481.00M1,909.00M
Share-based Compensation (Quarter)
2.74M0.90M0.61M0.63M0.57M0.46M0.33M0.29M0.10M0.52M0.18M0.10M0.10M0.10M0.08M0.10M0.20M0.37M0.40M0.50M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
-1.00
Cash from Operations (Quarter)
-3.12M-0.36M-3.21M-0.42M-3.03M-5.63M-1.79M-1.57M-1.81M-1.43M-1.41M-1.66M-0.86M-0.98M-1.52M-2.38M-1.70M-1.70M-2.10M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.08M0.05M0.05M0.05M0.05M0.04M0.04M0.02M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-3.56M-0.78M0.43M-2.50M0.17M-0.13M1.06M-2.20M-0.01M0.59M0.10M0.38M-0.56M-0.28M0.10M0.03M-0.11M0.36M-0.22M
Change in Inventory (Quarter)
Change in Accured Expenses (Quarter)
-3.59M0.51M0.29M1.57M2.46M-3.44M-0.94M0.29M-0.22M0.31M0.10M0.21M0.22M-0.52M0.03M-0.89M-0.26M0.40M-0.33M
Investing Activities
Capital Expenditures (Quarter)
0.00M-0.00M0.00M0.00M0.00M-41.00
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.00M0.00M-0.00M-0.00M-0.00M41.00
Financing Activities
Other financing activities (Quarter)
0.19M11.96M-11.96M1.00
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
1.77M2.26M2.21M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M
Net Equity Issued and Repurchased (Quarter)
0.02M-4.001.29M-1.29M11.96M3.03M20.00M0.83M0.48M0.32M0.28M0.14M0.63M6.87M0.22M3.50M
Misc.
Cash from Financing Activities (Quarter)
0.02M0.22M1.23M10.40M-286.002.91M0.76M0.74M0.41M0.31M0.21M0.11M-0.03M2.07M14.77M0.19M3.36M
Exchange Rate Effect (Quarter)
0.19M-0.08M0.02M0.02M-0.05M-0.09M0.06M0.01M0.05M-0.04M0.01M-0.02M-0.01M-0.01M-0.03M-0.06M0.17M-0.04M-0.01M
Change in Cash (Quarter)
-2.91M-0.21M-1.96M10.01M-3.08M-5.72M1.18M-0.80M-1.01M-1.10M-1.09M-1.47M-0.76M-1.00M0.53M12.33M-1.53M-1.57M1.26M
Free Cash Flow (Quarter)
-3.12M-0.35M-3.21M-0.42M-3.03M-5.63M-1.79M-1.57M-1.81M-1.43M-1.41M-1.66M-0.86M-0.98M-1.52M-2.38M-1.70M-1.70M-2.10M
Net Cash Flow (Quarter)
-3.11M-0.13M-1.98M9.98M-3.03M-5.63M1.12M-0.81M-1.06M-1.02M-1.10M-1.45M-0.75M-1.01M0.55M12.39M-1.70M-1.51M1.26M